Correlation Between Vertex Pharmaceuticals and Neutra Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Neutra Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Neutra Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and Neutra Corp, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Neutra Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Neutra Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Neutra Corp.

Diversification Opportunities for Vertex Pharmaceuticals and Neutra Corp

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vertex and Neutra is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Neutra Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neutra Corp and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Neutra Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neutra Corp has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Neutra Corp go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and Neutra Corp

Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to under-perform the Neutra Corp. But the stock apears to be less risky and, when comparing its historical volatility, Vertex Pharmaceuticals is 19.1 times less risky than Neutra Corp. The stock trades about -0.26 of its potential returns per unit of risk. The Neutra Corp is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  0.02  in Neutra Corp on October 8, 2024 and sell it today you would earn a total of  0.01  from holding Neutra Corp or generate 50.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.0%
ValuesDaily Returns

Vertex Pharmaceuticals  vs.  Neutra Corp

 Performance 
       Timeline  
Vertex Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vertex Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Neutra Corp 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neutra Corp are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Neutra Corp reported solid returns over the last few months and may actually be approaching a breakup point.

Vertex Pharmaceuticals and Neutra Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vertex Pharmaceuticals and Neutra Corp

The main advantage of trading using opposite Vertex Pharmaceuticals and Neutra Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Neutra Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neutra Corp will offset losses from the drop in Neutra Corp's long position.
The idea behind Vertex Pharmaceuticals and Neutra Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing